Advertisement

IgA Nephropathy: Current Views on Pathogenesis and Treatment

  • H. Sakai
Part of the International Yearbooks of Nephrology book series (IYNE, volume 1)

Abstract

IgA nephropathy was first described by Berger and Hinglais (1) in 1968, and has been referred to as Berger’s disease. The term IgA nephropathy in this chapter is limited to primary IgA nephropathy because mesangial deposits of IgA are observed in various other diseases (2). IgA nephropathy is known to be one of the most common types of primary glomerulonephritis in many parts of the world, and its prognosis is not so benign as was initially thought (3). The most urgent requirement in the study of IgA nephropathy is to determine its pathogenesis and treatment. The aim of this chapter is to summarize recent advances in the knowledge of these aspects of this disease.

Keywords

Renal Biopsy Specimen Mesangial Area Mesangial Deposit Henoch Schoenlein Purpura Trimetazidine Dihydrochloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berger, J. and Hinglais, N.: Les Depots intercapillaires d’IgA-IgG. J. Urol. (Paris) 74:694–695, 1968.Google Scholar
  2. 2.
    Clarkson, A.R.: IgA nephropathy: history, classification and geographic distribution. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 1–8.Google Scholar
  3. 3.
    D’Amico, G.: Idiopathic IgA mesangial nephropathy. Nephron 41:1–13, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Berger, J.: IgA glomerular deposits in renal disease. Transplant. Proc. 1:939–944, 1969.PubMedGoogle Scholar
  5. 5.
    Lamperi, S. and Carozzi, S.: Skin-muscle biopsy in patients with various nephropathies. Nephron 24:46–50, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Hall, R.P., Stachura, I., Cason, J., Whiteside, T.L. and Lawley, T.J.: IgA-containing circulating immune complexes in patients with IgA nephropathy. Am. J. Med. 74:56–63, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Berger, J., Yaneva, H., Nabarra, B. and Barbanel, C.: Recurrence of mesangial deposition after renal transplantation. Kidney Int. 7:232–241, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Sanfilippo, F., Croker, B.P. and Bollinger, R.B.: Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 33:370–376, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    Sakai, H.: Lymphocyte function in IgA nephropathy. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 176–187.Google Scholar
  10. 10.
    Egido, J., Julian, B.A. and Wyatt, R.J.: Genetic factors in primary IgA nephropathy. Nephrol. Dial. Transplant. 2:134–142, 1987.PubMedGoogle Scholar
  11. 11.
    Bene, M-C. and Faure, G.: Berger’s disease: Recent advances in immunology and genetics. Adv. Nephrol. 16:281–290, 1987.Google Scholar
  12. 12.
    Conley, M.E., Cooper, M.D. and Michael, A.F.: Selective deposition of IgA1 in IgA nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J. Clin. Invest. 66:1432–1436, 1980.PubMedCrossRefGoogle Scholar
  13. 13.
    Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Immunoglobulin A1 in IgA nepdhropathy. N. Eng. J. Med. 305:1159–1160, 1981.CrossRefGoogle Scholar
  14. 14.
    Valentijn, R.M., Radl, J., Haaijman, J.J., Vermeer, B.J., Weening, J.J., Kauffmann, R.H., Daha, M.R. and van Es, L.A.: Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int. 26:760–766, 1984.PubMedCrossRefGoogle Scholar
  15. 15.
    Andre, C., Berthoux, F.C., Andre, F., Gillon, J., Genin, C. and Sabatier, J-C.: Prevalence of IgA2 deposits in IgA nephropathies. N. Eng. J. Med. 303:1343–1346, 1980.CrossRefGoogle Scholar
  16. 16.
    Crago, S.S., Kutteh, W.H., Moro, I., Allansmith, M.R., Radl, J., Haaijman, J.J. and Mestecky, J.: Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J. Immunol. 132:16–18, 1984.PubMedGoogle Scholar
  17. 17.
    Lai, K-N., Chan, K.W., Lai, F.M-C., Ho, C.P., Yan, K.W., Lam, C.W.K. and Vallance-Owen, J.: The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy. Am. J. Clin. Pathol. 85:548–551, 1986.PubMedGoogle Scholar
  18. 18.
    Trascasa, M.L., Egido, J., Sancho, J. and Hernando, L.: IgA glomerulonephritis (Berger’s disease): Evidence of high serum levels of polymeric IgA. Clin. Exp. Immunol. 42:247–254, 1980.PubMedGoogle Scholar
  19. 19.
    Tomino, Y., Sakai, H., Miura, M., Endoh, M. and Nomoto, Y.: Detection of polymeric IgA in gloermuli from patients with IgA nephropathy. Clin. Exp. Immunol. 49:419–425, 1982.PubMedGoogle Scholar
  20. 20.
    Komatsu, N., Nagura, H., Watanabe, K., Nomoto, Y. and Kobayashi, K.: Mesangial deposits of J-chain linked polymeric IgA nephropathy. Nephron 33:61–64, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Bene, M-C., Faure, G. and Duheille, J.: IgA nephropathy: Characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin. Exp. Immunol. 47:527–534, 1982.PubMedGoogle Scholar
  22. 22.
    Kutteh, W., Prince, S.J. and Mestecky, J.: Tissue origins of human polymeric and monomeric IgA. J. Immunol. 128:990–995, 1982.PubMedGoogle Scholar
  23. 23.
    Monteiro, R.C., Halbwachs-Mecarelli, L., Roque-Barreira, M.C., Noel, L-H., Berger, J. and Lesavre, P.: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 28:666–671, 1985.PubMedCrossRefGoogle Scholar
  24. 24.
    Monteiro, R.C., Chevailler, A., Noel, L.H. and Lesavre, P.: Negatively-charged serum IgA detected by in vitro binding to cationic proteins in patients with IgA nephropathy. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), 1987, p. 394.Google Scholar
  25. 25.
    Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Specificity of IgA antibody in IgA nephropathy. Nephron 29:103–104, 1981.PubMedGoogle Scholar
  26. 26.
    Tomino, Y., Sakai, H., Endoh, M., Miura, M., Suga, T., Kaneshige, H. and Nomoto, Y.: Cross reactivity of eluted antibodies from renal tissues of patients with Henoch-Schoenlein purpura and IgA nephropathy. Am. J. Nephrol. 3:315–318, 1983.PubMedCrossRefGoogle Scholar
  27. 27.
    Tomino, Y., Sakai, H., Endoh, M., Suga, T., Miura, M., Kaneshige, H. and Nomoto, Y.: Cross reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy. Clin. Exp. Immunol. 51:605–611, 1983.PubMedGoogle Scholar
  28. 28.
    Tomino, Y., Sakai, H., Miura, M., Endoh, M., Suga, T. and Nomoto, Y.: Detection of antigenic substances in patients with IgA nephropathy. Contrib. Nephrol. 40:69–73, 1984.PubMedGoogle Scholar
  29. 29.
    Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M., Nomoto, Y., Umehara, K. and Hashimoto, K.: Specific binding of circulating IgA antibodies in patients with IgA nephropathy. Am. J. Kid. Dis. 3:149–153, 1985.Google Scholar
  30. 30.
    Nagy, J., Uj, M., Szucs, G., Trinn, Cs. and Burger, T.: Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritis. Clin. Nephrol. 21:259–262, 1984.PubMedGoogle Scholar
  31. 31.
    Russell, M.W., Mestecky, J., Julian, B.A. and Galla, J.H.: IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli J. Clin. Immunol. 6:74–86, 1986.PubMedCrossRefGoogle Scholar
  32. 32.
    Tomino, Y., Yagame, M., Omata, F., Nomoto, Y. and Sakai, H.: A case of IgA nephropathy associated with adeno and herpes simplex virus. Nephron, 47:258–261, 1987.PubMedCrossRefGoogle Scholar
  33. 33.
    McCoy, R.C., Abramowsky, C.R. and Tisher, C.C.: IgA nephropathy. Am. J. Pathol. 76:123–144, 1974.PubMedGoogle Scholar
  34. 34.
    Evans, D.J., Williams, D.G., Peters, D.K., Sissons, J.G.P., Boulton-Jones, J.M., Ogg, C.S., Cameron, J.S. and Hoffbrand, B.I.: Glomerular deposition of properdin in Henoch-Schoenlein syndrome and idiopathic focal nephritis. Br. Med. J. iii:326–328, 1973.CrossRefGoogle Scholar
  35. 35.
    Rauterberg, E.W., Lieberknecht, H-M., Wingen, A-M. and Ritz, E.: Complement membrane attack (MAC) in idiopathic IgA-gloemrulonephritis. Kidney Int. 31:820–829, 1987.PubMedCrossRefGoogle Scholar
  36. 36.
    Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Activation of complement by renal tissues from patients with IgA nephropathy. J. Clin. Pathol. 34:35–40, 1981.PubMedCrossRefGoogle Scholar
  37. 37.
    Wyatt, R.J., Kanayama, Y., Julian, B.A., Negoro, N., Sugimoto, S., Hudson, E.C. and Curd, J.G.: Complement activation in IgA nephropathy. Kidney Int. 31:1019–1023, 1987.PubMedCrossRefGoogle Scholar
  38. 38.
    McLean, R.H., Wyatt, R.J. and Julian, B.A.: Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura. Kidney Int. 26:855–860, 1984.PubMedCrossRefGoogle Scholar
  39. 39.
    Wyatt, R.J., Julian, B.A., Galla, J.H. and McLean, R.: Increased frequency of C3 fast alleles in IgA nephropathy. Disease Marker 2:419–428, 1984.Google Scholar
  40. 40.
    Tomino, Y., Miura, M., Suga, T., Endoh, M., Nomoto, Y. and Sakai, H.: Detection of IgA1-dominant immune complexes in peripheral blood mononuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Nephron 37:137–139, 1984.PubMedCrossRefGoogle Scholar
  41. 41.
    Sato, M., Kinugasa, E., Ideura, T. and Koshikawa, S.: Phagocytic activity of polymorphonuclear leukocyte in patients with IgA nephropathy. Clin. Nephrol. 19:166–171, 1983.PubMedGoogle Scholar
  42. 42.
    Roccatello, D., Coppo, R., Piccoli, G., Cordonnier, D., Martina, G., Rollino, C., Picciotto, G., Sena, L.M. and Amoroso, A.: Fc receptors blocking factors in IgA nephropathies. Clin. Nephrol. 23:159–168, 1985.PubMedGoogle Scholar
  43. 43.
    Lawrence, S., Pussell, B.A. and Charlesworth, J.A.: Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo. Clin. Nephrol. 19:280–283, 1983.PubMedGoogle Scholar
  44. 44.
    Ooi, Y.M. and Ooi, B.S.: Identification of a monocyte phogocytic defect in a subpopulation of patients with nephritis. Kidney Int. 23:851–854, 1983.PubMedCrossRefGoogle Scholar
  45. 45.
    Roccatello, D., Coppo, R., Basolo, B., Cordonnier, D., Picciotto, G., Sena, M. and Piccoli, G.: Interaction between macrophage system and IgA immune complexes in IgA nephropathy. Kidney Int. 24:423–424, 1983.Google Scholar
  46. 46.
    Roccatello, D., Coppo, R. and Piccoli, G.: Monocyte macrophage system function in primary IgA nephropathy. Contrib. Nephrol. 40:130–136, 1984.PubMedGoogle Scholar
  47. 47.
    Bannister, K.M., Hay, J., Clarkson, A.R. and Woodroffe, A.J.: Fc specific reticulo-endothelial clearance in SLE and glomerulonephritis. Am. J. Kidney Dis. 3:287–292, 1984.PubMedGoogle Scholar
  48. 48.
    D’Amico, G., Imbasciati, E., di Belgioioso, G.B., Bertoli, S., Fogazzi, G., Ferrario, F., Fellin, G., Ragni, A., Colasanti, G., Minetti, L. and Pomticelli, C.: Idiopathic IgA mesangial nephropathy. Medicine 64:49–60, 1985.PubMedGoogle Scholar
  49. 49.
    Sakai, H.: Immune system abnormalities in IgA nephropathy especially T-cell functions. Plasma Ther. Transfus. Technol 6:677–686, 1985.Google Scholar
  50. 50.
    Endoh, M., Suga, T. and Sakai, H.: IgG, IgA and IgM rheumatoid factors in patients with glomerulonephritis. Nephron 39:330–335, 1985.PubMedCrossRefGoogle Scholar
  51. 51.
    Sinico, R.A., Fornasieri, A., Oreni, N., Benuzzi, S. and D’Amico, D.: Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger’s disease). J. Immunol. 137:536–541, 1986.PubMedGoogle Scholar
  52. 52.
    Nomoto, Y., Miura, M., Suga, T., Endoh, M., Tomino, Y. and Sakai, H.: Cold reacting anti-nuclear factor (ANF) in families of patients with IgA nephropathy. Clin. Exp. Immunol. 58:63–67, 1984.PubMedGoogle Scholar
  53. 53.
    Nomoto, Y., Suga, T., Miura, M., Nomoto, H., Tomino, Y. and Sakai, H.: Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nepdhropathy. Clin. Exp. Immunol. 65:513–519, 1986.PubMedGoogle Scholar
  54. 54.
    Cederholm, B., Wieslander, J., Bygren, P. and Heinegard, D.: Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc. Natl. Acad. Sci. USA 83:6151–6155, 1986.PubMedCrossRefGoogle Scholar
  55. 55.
    Endoh, M., Suga, T., Miura, M., Tomino, Y., Nomoto, Y. and Sakai, H.: In vivo alteration of antibody production in patients with IgA nephropathy. Clin. Exp. Immunol. 57:564–570, 1984.PubMedGoogle Scholar
  56. 56.
    Coppo, R., Basolo, B., Rollino, C., Roccatello, D., Martina, G., Amore, A., Bongiorno, G. and Piccoli, G.: Mediterranean diet and primary IgA nephropathy. Clin. Nephrol. 26:72–82, 1986.PubMedGoogle Scholar
  57. 57.
    Sato, M., Takayama, K., Wakasa, M. and Koshikawa, S.: Estimation of circulating immune complexes following oral challenge with cow’s milk in patients with IgA nephropathy. Nephron 47:43–48, 1987.PubMedCrossRefGoogle Scholar
  58. 58.
    Sakai, H., Nomoto, Y., Tomino, Y., Endoh, M., Miura, M. and Suga, T.: Increases of in vitro and in vivo production of polyclonal IgA in patients and their family members with IgA nephropathy. In: Recent Advances in Mucosal Immunology, Part B (Eds. J.R. McGhee, J. Mestecky, P.L. Ogra and J. Bienenstock), Plenum Press, New York and London, 1987, pp. 1507–1514.Google Scholar
  59. 59.
    Lesavre, P.H., Digeon, M. and Bach, J.F.: Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin. Exp. Immunol. 48:61–69, 1982.PubMedGoogle Scholar
  60. 60.
    Yagame, M., Tomino, Y., Miura, M., Tanigaki, T., Suga, T., Nomoto, Y. and Sakai, H.: Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA). Clin. Exp. Immunol. 67:270–276, 1987.PubMedGoogle Scholar
  61. 61.
    Yap, H.K., Sakai, R.S., Woo, K.T., Lim, C.H. and Jordan, S.C.: Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy. Clin. Immunol. Immunopathol. 43:395–402, 1987.PubMedCrossRefGoogle Scholar
  62. 62.
    Nomoto, Y., Sakai, H. and Arimori, S.: Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am. J. Clin. Pathol. 71:158–160, 1979.PubMedGoogle Scholar
  63. 63.
    Sakai, H., Nomoto, Y., Arimori, S., Komori, K., Inouye, H. and Tsuji, K.: Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy. Am. J. Clin. Pathol. 72:452–456, 1979.PubMedGoogle Scholar
  64. 64.
    Cosio, F.G., Lam, S., Folami, A.O., Conley, M.E. and Michael, A.F.: Immune regulation of immunoglobulin production in IgA nephropathy. Clin. Immunol. Immunopathol. 23:430–436, 1982.PubMedCrossRefGoogle Scholar
  65. 65.
    Fiorini, G., Fornasier, A., Sinico, R., Colasanti, G., Gibelli, A., Corneo, R. and D’Amico, G.: Lymphocyte populations in the peripheral blood from patients with IgA nephropathy. Nephron 31:354–357, 1982.PubMedCrossRefGoogle Scholar
  66. 66.
    Feehally, J., Beattie, T.J., Brenchley, P.E.C., Coupes, B.M., Mallick, N.P. and Postlethwaite, R.J.: Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int. 29:924–931, 1986.CrossRefGoogle Scholar
  67. 67.
    Garcia-Hoyo, R., Lozano, L. and Egigo, J.: Immune abnormalities of IgA in six families with IgA nephropathy. In: Recent Advances in Mucosal Immunology, Part B (Eds. J.R. McGhee, J. Mestecky, P.L. Ogra and J. Beinenstock), Plenum Press, New York and London, 1987, pp. 1499–1505.Google Scholar
  68. 68.
    Bene, M-C., Faure, G., de Ligney, B.H., Kessler, M. and Duheille, J.: IgA nephropathy: Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the IgA versus IgG secreting cell membrane. J. Clin. Invest. 71:1342–1347, 1983.PubMedCrossRefGoogle Scholar
  69. 69.
    Egido, J., Blasco, R., Lozano, L., Sancho, J. and Garcia-Hoyo, R.: Immunological abnormalities in tonsils of patients with IgA nephropathy: inversion in the percentage of IgA versus IgG-bearing lymphocytes and increased polymeric IgA synthesis. Clin. Exp. Immunol. 57:101–106, 1984.PubMedGoogle Scholar
  70. 70.
    Egido, J., Blasco, R., Sancho, J., Lozano, L., Sanchez-Crespo, M. and Hernando, L.: Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin. Exp.Immunol. 47:309–316, 1982.PubMedGoogle Scholar
  71. 71.
    Hale, G.M., Mcintosh, S.L., Hiki, Y., Clarkson, A.R. and Woodroffe, A.J.: Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy. Kidney Int. 29:718–724, 1986.PubMedCrossRefGoogle Scholar
  72. 72.
    Waldo, F.B., Beischel, L. and West, C.D..: IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives. Kidney Int. 29:1229–1233, 1986.PubMedCrossRefGoogle Scholar
  73. 73.
    Elson, C.O.: T cell specific IgA switching and for IgA B-cell differentiation. Immunology Today 4:189–190, 1983.CrossRefGoogle Scholar
  74. 74.
    Sakai, H., Nomoto, Y. and Arimori, S.: Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy. Clin. Exp. Immunol. 38:243–248, 1979.PubMedGoogle Scholar
  75. 75.
    Egido, J., Blasco, R.A., Sancho, J. and Hernando,: Immunological abnormalities in healthy relatives of patients with IgA nephropathy. Am. J. Nephrol. 5:14–20, 1985.PubMedCrossRefGoogle Scholar
  76. 76.
    Chatenoud, L. and Bach, M-A.: Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus. Kidney Int. 20:267–274, 1981.PubMedCrossRefGoogle Scholar
  77. 77.
    Egido, J., Blasco, R., Sancho, J. and Lozano, L.: T-cell dysfunction in IgA nephropathy: Specific abnormalities in the regulation of IgA synthesis. Clin. Immunol. Immnopathol. 26:201–212, 1983.CrossRefGoogle Scholar
  78. 78.
    Rothschild, E. and Chatenoud, L.: T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis. Kidney Int. 25:557–564, 1984.PubMedCrossRefGoogle Scholar
  79. 79.
    Cagnoli, L., Beltrandi, E., Pasquali, S., Biagi, R., Casadei-Maldini, M., Rossi, L. and Zucchelli, P.: B and T cell abnormalities in patients with primary IgA nephropathy. Kidney Int. 28:646–651, 1985.PubMedCrossRefGoogle Scholar
  80. 80.
    Endoh, M., Sakai, H., Nomoto, Y., Tomino, Y. and Kaneshige, H.: IgA-specific helper activity of Tα cells in human peripheral blood. J. Immunol. 127:2612–2613, 1981.PubMedGoogle Scholar
  81. 81.
    Sakai, H., Endoh, M., Tomino, Y. and Nomoto, Y.: Increase of IgA specific helper Tα cells in patients with IgA nephropathy. Clin. Exp. Immunol. 50:77–82, 1982.PubMedGoogle Scholar
  82. 82.
    Suga, T., Endoh, M., Sakai, H., Miura, M., Tomino, Y. and Nomoto, Y.: Tα cell subsets in human peripheral blood. J. Immunol. 134:1327–1329, 1985.PubMedGoogle Scholar
  83. 83.
    Sakai, H., Yasumoto, Y., Suga, T., Endoh, M., Tomino, Y. and Nomoto, Y.: Increase of IgA-specific switch T cells in patients with IgA nephropathy. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 402.Google Scholar
  84. 84.
    Kawanishi, H., Saltzman, L.E. and Strober, W.: Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. 1. T cells derived from Peyer’s patches that switch sIgM B cells to sIgA B cells in vitro. J. Exp. Med. 157:433–450, 1983.PubMedCrossRefGoogle Scholar
  85. 85.
    Yodoi, J., Adachi, M. and Noro, N.: IgA binding factors and Fc receptors for IgA: Comparative studies between IgA and IgE Fc receptor system. Int. Rev. Immunol. 2:117–141, 1987.PubMedCrossRefGoogle Scholar
  86. 86.
    Harriman, G.R. and Strober, W.: Interleukin 5, a mucosal lymphokine? J. Immunol. 139:3553–3555, 1987.PubMedGoogle Scholar
  87. 87.
    Power, D.A., Muirhead, N., Simpson, J.G., Nicholls, A.J., Horne, C.H.W., Gotto, G.R.D. and Edward, N.: IgA nephropathy is not a rare disease in the United Kingdom. Nephron 40:180–184, 1985.PubMedCrossRefGoogle Scholar
  88. 88.
    Jennette, J.C., Wall, S.D. and Wilkman, A.S., Kideny Int.: Low incidence of IgA nephropathy in blacks. 28:944–950, 1985.Google Scholar
  89. 89.
    Julian, B.A., Quiggins, P.A., Thompson, J.S., Woodford, S.Y., Gleason, K. and Wyatt, R.J.: Familial IgA nephropathy. Evidence for an inherited mechanism of disease. N. Eng. J. Med. 312:202–208, 1985.CrossRefGoogle Scholar
  90. 90.
    Wyatt, R.J., Rivas, M.L., Julian, B.A., Quiggins, P.A., Woodford, S.Y., McMorrow, R.G. and Beahler, R.W.: Regionalization in hereditary IgA nephropathy. Am. J. Hum. Genet. 41:36–50, 1987.PubMedGoogle Scholar
  91. 91.
    Julian, B.A., Phillips, J.A.III., Orlando, P.J., Wyatt, R.J. and Butler, M.G.: Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy. Seminar in Nephrol. 7:306–310, 1987.Google Scholar
  92. 92.
    Rambausek, M., Knight, J.F., Williams, D.G., Welsh, K.I., Ritz, E. and Demaine, A.G.: Relation of mesangial IgA-GN to polymorphism of immunoglobulin heavy chain switch region. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 400.Google Scholar
  93. 93.
    Davin, J.D., Malaise, M., Foidart, J.B. and Mahieu, P.: Evidence that carbohydrates of the Fc domain of IgA are involved in the formation of large IgA-immune complexes in IgA-associated nephropathies. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 322.Google Scholar
  94. 94.
    DeWerra, P., Morel-Marogeer, L., Leroux-Robert, C. and Richet, P.: Glomerulites a depots d’IgA diffus dans le mesangium. Schweiz. Med. Wochenschr. 761–768, 797–803, 1973.Google Scholar
  95. 95.
    Sissons, J.G., Woodrow, D.F., Curtis, J.G., Evans, D.J., Goover, P.E. and Slopper, J.G.: Isolated glomerulonephritis with mesangial IgA deposits. Br. Med. J. iii:611–614, 1975.CrossRefGoogle Scholar
  96. 96.
    Tolkoff-Rubin, N.E., Cosimi, A.B., Fuller, T., Rubin, R.H. and Colvin, R.B.: IgA nephropathy in HLA-identical siblings. Transplantation 26:430–433, 1978.PubMedCrossRefGoogle Scholar
  97. 97.
    Yoshikawa, T., Ito, H., Nakahara, C., Yoshihara, S., Yoshiya, K., Matsuo, T., Hasegawa, O., Hazikano, H. and Okada, S.: Glomerular electron-dense deposits in childhood IgA nephropathy. Virchows Arch. A. 406:33–43, 1985.CrossRefGoogle Scholar
  98. 98.
    Hogg, R.J. and Silva, F.G.: IgA nephropathy in children. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 16–38.Google Scholar
  99. 99.
    Droz, D.: IgA nephropathy: clinicopathological correlations. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 97–107.Google Scholar
  100. 100.
    D’Amico, G., Minetti, L., Ponticelli, C., Fellin, G., Ferrario, F., Barbiano di Belgioioso, G., Imbasciati, E., Ragni, A., Bertoli, S., Fogazzi, G. and Duca, G.: Prognostic indicators in idiopathic IgA mesangial nephropathy. Quart. J. Med. New Series 59:363–378, 1986.Google Scholar
  101. 101.
    Tojo, S., Narita, M., Miyahara, T., Sakai, O., Ohno, J., Soeda, N., Honda, N., Nagase, M., Sibata, M., Orita, Y., Ishikawa, H., Hara, K. and Sakuma, A.: Manseisikyuutaijinen ni taisuru trimetazidine dihydrochloride no rinshokouka. Jin to Toseki 19:1367–1380, 1985.Google Scholar
  102. 102.
    Tojo, S., Honda, N., Sibata, M., Narita, M., Miyahara, T., Sakai, O., Katoh, E., Kida, H., Orita, Y., Ishikawa, H., Hara, K., Tanaka, T. and Takasaki, H.: Manseisikyuutaijinen ni tausuru AS-05 (Dilazep) no rinshouhyouka. Jin to Toseki 20:289–313, 1986.Google Scholar
  103. 103.
    Kobayashi, Y., Fujii, K., Hiki, Y. and Tateno, S.: Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. Quart. J. Med. New Series 61:935–943, 1986.Google Scholar
  104. 104.
    Laurent, J., Belghiti, D., Bruneau, C. and Lagrue, G.: Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: A controlled study. Am. J. Nephrol. 7:198–202, 1987.PubMedCrossRefGoogle Scholar
  105. 105.
    Hamazaki, T., Tateno, S. and Shishido, H.: Eicosa-pentaenoic acid and IgA nephropathy. Lancet i: 1017–1018, 1984.CrossRefGoogle Scholar
  106. 106.
    Tomino, Y., Miura, M., Suga, T., Endoh, M., Nomoto, Y. and Sakai, H.: Defibrination of intraglomurular fibrin deposits by urokinase in patients with IgA nephropathy. Jpn. J. Nephrol. 26:275–280, 1984.Google Scholar
  107. 107.
    Miura, M., Tomino, Y., Yagame, M., Inoue, W., Suga, T., Nomoto, Y. and Sakai, H.: Significant correlation between the immunofluorescence of alpha 2-plasmin inhibitor in glomeruli and the effects of urokinase therapy in patients with IgA nephropathy. Annals Acad. Med. 15:255–257, 1986.Google Scholar
  108. 108.
    Tomino, Y., Sakai, H., Suga, T., Miura, M., Kaneshige, H., Endoh, M. and Nomoto, Y.: Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. Am. J. Kidney Dis. 3:48–53, 1983.PubMedGoogle Scholar
  109. 109.
    Tomino, Y., Sakai, H., Woodroffe, A.J. and Clarkson, A.R.: Studies on glomerular immune solubilization by complement in patients with IgA nephropathy. Acta Pathol. Jpn. 37:1763–1767, 1987.PubMedGoogle Scholar
  110. 110.
    Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M. and Nomoto, Y.: Effect of danazol on solubilization of immune deposits in patients with IgA nephropathy. Am. J. Kidney Dis. 4:135–140, 1984.PubMedGoogle Scholar
  111. 111.
    Tomino, Y., Sakai, H., Hanzawa, S., Ohno, J., Kitajima, T. and Sakai, O.: Clinical effect of Danazol in patients with IgA nephropathy. Jpn. J. Med. 26:162–166, 1987.PubMedCrossRefGoogle Scholar
  112. 112.
    Beukhof, H.R., ter Wee, P.M., Sluiter, W.J. and Donker, A.J.M.: Effect of low-dose dopamine on effective renal plasma flow and glomerular filtration rate in 32 patients with IgA nephropathy. Am. J. Nephrol. 5:267–270, 1985.PubMedCrossRefGoogle Scholar
  113. 113.
    Lopez-Trascasca, M., Egido, J., Sancho, J. and Hernando, L.: Evidence of high polymeric IgA levels in serum of patients with Berger’s disease and its modification with phenytoin treatment. Proc. Eur. Dial. Transplant. Assoc. 16: 513, 1979.Google Scholar
  114. 114.
    Clarkson, A.R., Seymour, A.E., Woodroffe, A.J., McKenzie, P.E., Chan, Y-L. and Wootton, A.M.: Controlled trial of phenytoin therapy in IgA nephropathy. Clin. Nephrol. 13:215–218, 1980.PubMedGoogle Scholar
  115. 115.
    Coppo, R., Blasco, B., Bulzomi, M.R. and Piccoli, G.: Ineffectiveness of phenytoin treatment on IgA-containing circulating immune complexes in IgA nephropathy. Nephron 36:275–276, 1984.PubMedCrossRefGoogle Scholar
  116. 116.
    Coppo, R., Basolo, B., Giachino, O., Rocatelli, D., Lajola, D., Mazzucco, G., Amore, A. and Picoli, G.: Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: removal of IgA-containing immune complexes and clinical recovery. Nephron 40:488–490, 1985.PubMedCrossRefGoogle Scholar
  117. 117.
    Clarkson, A.R.: The treatment of IgA nephropathy. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, p. 219.Google Scholar
  118. 118.
    Cameron, J.S. and Turner, D.R.: Recurrent glomerulonephritis in allografted kidneys. Clin. Nephrol. 7:47–51, 1977.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • H. Sakai
    • 1
  1. 1.Division of Nephrology and Metabolism, Department of Internal Medicine, School of MedicineTokai UniversityIsehara City, Kanagawa-kenJapan

Personalised recommendations